Malaria in Brazil: RBC variants & parasite invasion
Malaria in Brazil: RBC variants & parasite invasion
批准号:
7657936
负责人:
Sara Lustigman
金额:
$30.08万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-01 至 2010-02-28
关键词:
AdmixtureAllelesAntigensAreaBindingBiological AssayBlood Group AntigensBrazilCase-Control StudiesCell surfaceCellsCharacteristicsComparative StudyContractsControl GroupsCountryDependenceDevelopmentEnzymesErythrocytesEthnic OriginFalciparum MalariaFamilyFrequenciesFutureGYPA geneGenesGeneticGenetic PolymorphismGenetic VariationGenotypeGlycophorinGlycophorin AGlycophorin BGoalsHaplotypesHybridsImmune responseIn VitroIndividualInfectionInvadedLaboratoriesLifeLigandsLinkage DisequilibriumMalariaMeasuresMolecularMorbidity - disease rateNeuraminidaseNumbersPAR-2 ReceptorParasitesPathway interactionsPhenotypePlasmodium falciparumPliabilityPopulationPositioning AttributePredispositionProcessRH1RangeResistanceRiskSiteSpecificityStructureSubgroupSurfaceTestingTimeTrypsinVaccinesVariantbasecase controlchymotrypsinfield studynovelparasite invasionprospectivereceptorsizevaccine development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A growing body of evidence indicates that the risk of acquiring malaria and morbidity is determined by host
genetic factors and the genotype of the infecting parasite strain. The major goal of this study is to better
understand the impact that polymorphisms in RBC receptors, specifically glycophorin B (GPB), as well as the
impact that the parasites¿ repertoire of invasion ligand variants have on the variety of invasion pathways used
by P. falciparum in two endemic regions of the Brazilian Amazon. The merozoites of P. falciparum invade
through several pathways using different RBC receptors, which include the glycophorins (GPA, GPB and
GPC), Band 3 and others whose identity has not yet been determined. RBC specificity is dependent on ligandreceptor
interactions and these are not static in P. falciparum, partly to provide greater flexibility to the parasite.
Field isolates may show even greater variability than do the laboratory isolates in which these pathways have
been defined. The underlying hypothesis of this application is that both host and parasite genetic factors may
drive the emergence of distinct RBC invasion pathways in P. falciparum endemic regions. To better understand
the contribution of host and parasite factors involved in this process, we will study the highly admixed Brazilian
Amazon population and the parasites to which they are exposed. Our initial studies have shown that the
GPB S variant is more frequent in individuals who have P. falciparum infection in two endemic regions in
Brazil. Moreover, we found that the Amazonian isolates have limited repertoire of invasion ligands when
compared to laboratory strains and that they express unique variants some of which are associated with a
defined invasion profile of the corresponding field isolates. To better understand RBC invasion by P. falciparum
in the field and determine whether the molecular interactions between parasite ligands and RBC receptors
observed in laboratory isolates are relevant to malaria infection in the field the following aims are proposed: 1)
To establish whether molecular variation in the GYPB gene, particularly the one that generates the GYPB*S/s
alleles, influences host susceptibility to infection with P. falciparum in two distinct Brazilian Amazon endemic
regions. The allelic and haplotypic frequencies of the various GYPB variants will be compared between
ethnically matched case and control groups within each endemic site, and between sites. 2) To determine the
impact of defined GYPB polymorphisms on RBC invasion by a subgroup of Brazilian Amazon field isolates that
predominantly uses the GPB invasion pathway. 3) To study the association between P. falciparum ligand
polymorphisms and the RBC invasion profiles used by the Amazonian field isolates and/or the ability of the
variant ligand to bind to RBCs with defined phenotypes. Our studies will likely generate a greater focus on GPB
as an important RBC receptor for field isolates invasion, and motivate the search for the GPB parasite ligand
which could then become also an important vaccine candidate. Our studies could also impact development of
global vaccines against P. falciparum malaria that target multiple determinants of merozoite invasion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Restoring age-dependent vaccine unresponsiveness by a novel ASP-1 adjuvant combination
-
批准号:10458553
-
项目类别:
-
资助金额:$71.94万
-
财政年份:2021
-
负责人:Sara Lustigman
-
依托单位:
Restoring age-dependent vaccine unresponsiveness by a novel ASP-1 adjuvant combination
-
批准号:10220588
-
项目类别:
-
资助金额:$73.71万
-
财政年份:2021
-
负责人:Sara Lustigman
-
依托单位:
Restoring age-dependent vaccine unresponsiveness by a novel ASP-1 adjuvant combination
-
批准号:10620718
-
项目类别:
-
资助金额:$71.94万
-
财政年份:2021
-
负责人:Sara Lustigman
-
依托单位:
Activating autophagy in filarial worms to identify novel macrofilaricides
-
批准号:10198729
-
项目类别:
-
资助金额:$25.88万
-
财政年份:2020
-
负责人:Sara Lustigman
-
依托单位:
Activating autophagy in filarial worms to identify novel macrofilaricides
-
批准号:10040523
-
项目类别:
-
资助金额:$23.79万
-
财政年份:2020
-
负责人:Sara Lustigman
-
依托单位:
The development of a recombinant vaccine against human onchocerciasis
-
批准号:7919994
-
项目类别:
-
资助金额:$71.43万
-
财政年份:2009
-
负责人:Sara Lustigman
-
依托单位:
The development of a recombinant vaccine against human onchocerciasis
-
批准号:8512650
-
项目类别:
-
资助金额:$60.38万
-
财政年份:2009
-
负责人:Sara Lustigman
-
依托单位:
The development of a recombinant vaccine against human onchocerciasis
-
批准号:9444432
-
项目类别:
-
资助金额:$69.48万
-
财政年份:2009
-
负责人:Sara Lustigman
-
依托单位:
Malaria in Brazil: RBC variants & parasite invasion
-
批准号:7913592
-
项目类别:
-
资助金额:$31.56万
-
财政年份:2009
-
负责人:Sara Lustigman
-
依托单位:
The development of a recombinant vaccine against human onchocerciasis
-
批准号:7738645
-
项目类别:
-
资助金额:$70.83万
-
财政年份:2009
-
负责人:Sara Lustigman
-
依托单位:
The development of a recombinant vaccine against human onchocerciasis
-
批准号:8306946
-
项目类别:
-
资助金额:$65.32万
-
财政年份:2009
-
负责人:Sara Lustigman
-
依托单位:
The development of a recombinant vaccine against human onchocerciasis
-
批准号:8099714
-
项目类别:
-
资助金额:$67.95万
-
财政年份:2009
-
负责人:Sara Lustigman
-
依托单位:
A Helminth-Derived Immune Potentiator for Biodefense
-
批准号:6966960
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2005
-
负责人:Sara Lustigman
-
依托单位:
A Helminth-Derived Immune Potentiator for Biodefense
-
批准号:7140427
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2005
-
负责人:Sara Lustigman
-
依托单位:
Malaria Invasion Via Glycophorin B in Brazilian Isolates
-
批准号:7096613
-
项目类别:
-
资助金额:$3.22万
-
财政年份:2005
-
负责人:Sara Lustigman
-
依托单位:
Malaria Invasion Via Glycophorin B in Brazilian Isolates
-
批准号:7234772
-
项目类别:
-
资助金额:$3.13万
-
财政年份:2005
-
负责人:Sara Lustigman
-
依托单位:
Malaria Invasion Via Glycophorin B in Brazilian Isolates
-
批准号:6989210
-
项目类别:
-
资助金额:$4.22万
-
财政年份:2005
-
负责人:Sara Lustigman
-
依托单位:
Malaria invasion: Red cell receptor /ligand interactions
-
批准号:6840412
-
项目类别:
-
资助金额:$42.8万
-
财政年份:2004
-
负责人:Sara Lustigman
-
依托单位:
Cysteine Proteases & Inhibitors in Nematode Development
-
批准号:6632455
-
项目类别:
-
资助金额:$30.99万
-
财政年份:2001
-
负责人:Sara Lustigman
-
依托单位:
Cysteine Proteases & Inhibitors in Nematode Development
-
批准号:6511554
-
项目类别:
-
资助金额:$30.99万
-
财政年份:2001
-
负责人:Sara Lustigman
-
依托单位:
海外基金